Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check7 days agoChange DetectedDate-only updates were made to the Study Record Dates (e.g., 2025-10-29, 2025-10-27) with earlier dates removed. These are routine timestamp updates and do not modify trial design, eligibility, or results.SummaryDifference0.5%

- Check14 days agoChange DetectedAdded an estimated 'Last Update Posted' timestamp with new dates (2025-09 and 2025-10) and removed earlier entries (2025-07 and 2025-08).SummaryDifference0.2%

- Check36 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference2%

- Check43 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no other substantive content changes observed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.